Recall Notice: Heparin Sodium (B. Braun): Recall - Trace Contaminant

On October 29, 2010 B. Braun Medical Inc. and the FDA notified healthcare professionals of a nationwide recall of certain lots of Heparin Sodium USP Active Pharmaceutical Ingredient (API) sold to B. Braun because testing indicated trace amounts of oversulfated chondroitin sulfate (OSCS) contaminant. These lots were manufactured in 2008 and will be expiring on October 31, 2010 and November 30, 2010. Should you be in possession of this product discontinue use immediately. To identify product lot numbers, expiration dates, and recall instructions please, reference the Recall Notice contained in the following link. Click here for more information.